Clinical Trial

Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients

Completed
View on ClinicalTrials.gov →
Summary
This is an observational study related to a medical device designed for the prevention of oxaliplatin-induced peripheral neuropathy (OIPN) in patients with gastrointestinal cancer. The primary objective is to collect data through interviews with patients experiencing OIPN symptoms to co-design the medical device prototype, incorporating the patient's perspective. Additionally, the study aims to identify clinical and usability patterns that will help optimize the design of a future clinical investigation assessing the safety and efficacy of the final device.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-06; most recent amendment 2026-03-07.
Status change: Recruiting → Completed 2026-03-07
Status change: Not Yet Recruiting → Recruiting 2025-05-05
Trial Details
NCT Number NCT06873360
Lead Sponsor Corporacion Parc Tauli
Conditions Peripheral Neuropathy Due to Chemotherapy
Enrollment 50 participants
Start Date 2025-04-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-10